本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Scinai Immunotherapeutics Ltd.

2.74
-0.0775-2.75%
成交量:5,554.00
成交額:1.53萬
市值:255.83萬
市盈率:0.33
高:2.85
開:2.76
低:2.70
收:2.82
資料載入中...
2025/03/11

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/03/04

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/20

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/05/15

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/12

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

SEC問詢函

Form CORRESP - Correspondence
2024/01/25

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/26

SEC問詢函

Form CORRESP - Correspondence
2023/12/22

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/10/31

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2023/08/23

SEC問詢函

Form CORRESP - Correspondence
2023/06/08

重要事件披露

Form 8-K - Current report
2023/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/11

重要事件披露

Form 8-K - Current report
2023/05/04

重要事件披露

Form 8-K - Current report
2023/05/04

重要事件披露

Form 8-K - Current report
2023/04/17

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/04/17

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans